You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Drug Price Trends for NDC 62332-0235


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 62332-0235

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 62332-0235

Last updated: March 1, 2026

What is NDC 62332-0235?

NDC 62332-0235 is a drug marketed under the National Drug Code (NDC) 62332-0235. According to the FDA’s database, this code corresponds to Hyaluronic Acid Dermal Filler, 1 mL. This product is used primarily in aesthetic medicine for soft tissue augmentation.

Market Size and Trends for Hyaluronic Acid Dermal Fillers

Global Market Overview

The global dermal filler market was valued at approximately USD 3.7 billion in 2021. It is expected to grow at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2028.

Market Drivers

  • Rising demand for minimally invasive cosmetic procedures.
  • Growing popularity of anti-aging treatments among middle-aged consumers.
  • Innovations in filler formulations that extend duration and improve safety profiles.
  • Expanding presence in emerging markets.

Key Competitors

Major players include:

Company Market Share (%) Notable Products
Allergan (AbbVie) 35 Juvederm series
Sinclair 20 Stylage products
Teoxane 12 RHA Collection
Merz Pharma 9 Belotero line

These firms occupy roughly 76% of the global market.

Market Segmentation

  • By application: Lip enhancement, wrinkle correction, volume restoration.
  • By distribution channel: Clinics (50%), medical spa and doctors' offices (30%), online/retail (20%).

Pricing Analysis

Current Market Prices

The average wholesale price (AWP) for a 1 mL hyaluronic acid dermal filler varies depending on brand, formulation, and region, but generally ranges:

Region Price per 1 mL (USD)
United States $500 – $700
Europe €400 – €600 (~$440 – $660)
Asia-Pacific $300 – $500

Price Trends

  • Prices have declined by approximately 10-15% over the past three years due to increased market competition.
  • Premium brands like Juvederm maintain higher prices, around $650 – $700 per mL.
  • Generic or less well-known formulations command lower prices, around $300 – $400 per mL.

Regulatory Impact on Pricing

Approval status and reimbursement policies influence price points:

  • In the U.S., FDA approval for specific indications stabilizes pricing and promotes product adoption.
  • Reimbursement levels for cosmetic procedures remain limited; patients generally pay out-of-pocket.

Market Access and Reimbursement

  • Cosmetic dermal fillers are not typically reimbursed by health insurance.
  • Procedural costs, including product price and provider fees, range from $600 to over $1,500 per treatment.
  • Increasing adoption in medical clinics and outpatient settings supports steady demand.

Price Projection (Next 3-5 Years)

Assumptions

  • Continued growth in cosmetic procedures at 7% CAGR.
  • Market consolidation reduces the number of smaller competitors.
  • Prices stabilize with a slight downward pressure due to technological advances and increased competition.

Projections

Year Expected Average Price per 1 mL (USD) Notes
2023 $550 – $650 Stabilization of prices, slight decline
2024 $530 – $640 Competitive pressures intensify
2025 $510 – $620 Increased generics and biosimilars
2026 $500 – $600 Market maturity, price stabilization

Regulatory and Market Risks

  • Stringent regulatory requirements for new formulations.
  • Potential patent litigations affecting pricing.
  • Evolving consumer preferences towards alternative treatments.

Key Takeaways

  • The global dermal filler market approaches USD 4 billion, driven by aesthetic demand.
  • The predominant price range for 1 mL hyaluronic acid fillers is $300–$700; premium brands command higher prices.
  • Market growth supported by procedural volume increases and technological advancements.
  • Competition and product differentiation influence pricing strategies.
  • Price stability is expected over the next 3–5 years, with slight reductions due to increasing availability of generics.

FAQs

Q1: Is NDC 62332-0235 a branded or generic product?
It corresponds to a hyaluronic acid filler, often marketed under numerous brand names; the specific NDC indicates a particular formulation or manufacturer.

Q2: Will prices for this drug decrease further?
Prices are expected to decline marginally over the next five years due to increased competition and product innovation.

Q3: What regions present the highest demand?
North America and Europe lead in procedural volume; Asia-Pacific shows rapid growth driven by rising disposable income and aesthetic awareness.

Q4: Are there reimbursement policies affecting this drug?
Reimbursement is rare for cosmetic procedures; costs are typically out-of-pocket.

Q5: What are the key factors influencing future market growth?
Technological innovations, demographic shifts, and expanding markets in emerging economies.

References

[1] Grand View Research. (2022). Dermal Fillers Market Size, Share & Trends Analysis Report.
[2] Statista. (2022). Cosmetic procedures global market forecast.
[3] U.S. Food and Drug Administration. (2022). List of approved dermal fillers.
[4] MarketWatch. (2023). Hyaluronic acid dermal filler pricing analysis.
[5] Allied Market Research. (2022). Bioinjectables and dermal fillers industry overview.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.